These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38540372)

  • 1. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry.
    Tesorero R; Janda J; Hörster F; Feyh P; Mütze U; Hauke J; Schwarz K; Kunz JB; Hoffmann GF; Okun JG
    PLoS One; 2023; 18(3):e0283024. PubMed ID: 36897914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
    Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
    Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR.
    Czibere L; Burggraf S; Fleige T; Glück B; Keitel LM; Landt O; Durner J; Röschinger W; Hohenfellner K; Wirth B; Müller-Felber W; Vill K; Becker M
    Eur J Hum Genet; 2020 Jan; 28(1):23-30. PubMed ID: 31363188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy.
    Liu Z; Zhang P; He X; Liu S; Tang S; Zhang R; Wang X; Tan J; Peng B; Jiang L; Hong S; Zou L
    BMC Neurol; 2016 Aug; 16(1):141. PubMed ID: 27534852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state.
    Kraszewski JN; Kay DM; Stevens CF; Koval C; Haser B; Ortiz V; Albertorio A; Cohen LL; Jain R; Andrew SP; Young SD; LaMarca NM; De Vivo DC; Caggana M; Chung WK
    Genet Med; 2018 Jun; 20(6):608-613. PubMed ID: 29758563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
    Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
    [No Abstract]   [Full Text] [Related]  

  • 14. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the performance of four assays for carrier screening of spinal muscular atrophy.
    Tan J; Zhang J; Sun R; Jiang Z; Wang Y; Ma D; Jiao J; Chen H; Lin Y; Zhang Q; Xu Z; Hu P
    Clin Chim Acta; 2023 Aug; 548():117496. PubMed ID: 37479010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for spinal muscular atrophy in Japan: One year of experience.
    Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K
    Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. California's experience with SMA newborn screening: A successful path to early intervention.
    Matteson J; Wu CH; Mathur D; Tang H; Sciortino S; Feuchtbaum L; Bishop T; Sharma SC; Neogi P; Fitzgibbon I; Olney RS
    J Neuromuscul Dis; 2022; 9(6):777-785. PubMed ID: 36278357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
    Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM
    Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new line method; A direct test in spinal muscular atrophy screening for DBS.
    Kubar A; Temel SG; Beken S; Onder G; Hatirnaz O; Korkmaz A; Alanay Y; Ozbek U; Sag SO; Ergoren MC; Kubar E; Sonmezalp CZ; Doğan O
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2270. PubMed ID: 37614112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.